Am J Transplant 2007 7 2619-2625.Larsen CP Grinyo J Medina-Pestana J et al.

Am J Transplant 2015 15 472-481.Ison MG Hager J Blumberg E et al.

Am J Transplant 2011 11 336-347.Savoldo B Goss J Liu Z et al.

J Infect 2012 65 453-464.Briegel J Forst H Spill B et al.

What is the impact of hypogammaglobulinemia on the rate of infections and survival in solid organ transplantation A meta- analysis Am J Transplant 2013 13 2601-2610.Husain S Raza K Pilewski JM et al.

Pathogen- specific immune assays suggest the relative risk of cer- tain infections however in the face of intensive immunosuppression protective immunity while useful tends to dissipate.Risk of Infection and the Timeline of InfectionThe risk of infection for the recipient at any point in time after transplantation is a function of two factorsThe epidemiologic exposures of the patient and the organ donor including recent nosocomial and remote exposures Table 1 8.The patient's net state of immunosuppression including all factors contributing to the risk of infection Table 2.Table 1 Epidemiologic exposures relevant to transplantation1 VirusHerpes group CMV EBV HHV6 7 8 HSV VZVHepatitis viruses HAV HBV HCV HEVRetroviruses HIV HTLV-1 and 2Others West Nile WNV Chikungunya Zika Dengue lymphocytic choriomeningitis virus rabies BacteriaGram-positive and gram-negative bacteria Staphylococcus spp.

J Clin Invest 2003 111 1887-1895.Selin LK Cornberg M Brehm MA et al.

Am J Transplant 2009 9Suppl 4 S19-S26.Green M Covington S Taranto S et al.

Am J Trans- plant 2011 11 1201-1208.Kucirka LM Sarathy H Govindan P et al.

Am J Transplant 2011 11 1188-1200.Kucirka LM Sarathy H Govindan P et al.

